Md. Code Ann., Health-Gen. § 3-403 – Committee on Registered Nurses Personally Preparing and Dispensing Drugs and Devices in Local Health Departments

(a)
1. (1) There is a Committee on Registered Nurses Personally Preparing and Dispensing Drugs and Devices in Local Health Departments.
2. (2) The Committee consists of the following members:
  1. (i) A representative of the Department, appointed by the Department;
  2. (ii) A representative of the State Board of Nursing, appointed by the State Board of Nursing;
  3. (iii) A representative of the State Board of Pharmacy, appointed by the State Board of Pharmacy;
  4. (iv) A representative of the State Board of Physicians, appointed by the State Board of Physicians;
  5. (v) A pharmacist who practices in the State, appointed by the State Board of Pharmacy;
  6. (vi) A registered nurse who practices in the State, appointed by the State Board of Nursing;
  7. (vii) A representative of the Office of Controlled Substances Administration, appointed by the Office; and
  8. (viii) A representative of a local health department, appointed by the Department.
3. (3)
  1. (i) The term of a member is 4 years.
  2. (ii) At the end of a term, a member continues to serve until a successor is appointed.
4. (4) A member of the Committee:
  1. (i) May not receive compensation as a member of the Committee; but
  2. (ii) Is entitled to reimbursement for expenses under the Standard State Travel Regulations, as provided in the State budget.
5. (5) The Secretary shall designate the chair of the Committee.
6. (6) The Department shall provide staff for the Committee.
(b) The Committee shall:
1. (1) Develop and approve a formulary for use by registered nurses that includes all nonprescription contraceptive drugs and devices approved by the U.S. Food and Drug Administration for over-the-counter use; and
2. (2) Annually review the formulary to ensure compliance with current prescribing standards.

Added by Acts 2015, c. 44, § 1, eff. June 1, 2015. Amended by Acts 2017, c. 62, § 1, eff. April 11, 2017; Acts 2024, c. 932, § 1, eff. Oct. 1, 2024; Acts 2024, c. 933, § 1, eff. Oct. 1, 2024.